These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32100392)

  • 1. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells.
    Wang X; Shao X; Gu L; Jiang K; Wang S; Chen J; Fang J; Guo X; Yuan M; Shi J; Ding C; Meng S; Xu Q
    J Cell Mol Med; 2020 Apr; 24(7):4286-4297. PubMed ID: 32100392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.
    Shao X; Wang X; Guo X; Jiang K; Ye T; Chen J; Fang J; Gu L; Wang S; Zhang G; Meng S; Xu Q
    Front Oncol; 2019; 9():436. PubMed ID: 31192135
    [No Abstract]   [Full Text] [Related]  

  • 3. Oncolytic Newcastle disease virus induces autophagy-dependent immunogenic cell death in lung cancer cells.
    Ye T; Jiang K; Wei L; Barr MP; Xu Q; Zhang G; Ding C; Meng S; Piao H
    Am J Cancer Res; 2018; 8(8):1514-1527. PubMed ID: 30210920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.
    Jiang K; Li Y; Zhu Q; Xu J; Wang Y; Deng W; Liu Q; Zhang G; Meng S
    BMC Cancer; 2014 Jul; 14():551. PubMed ID: 25078870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death.
    Koks CA; Garg AD; Ehrhardt M; Riva M; Vandenberk L; Boon L; De Vleeschouwer S; Agostinis P; Graf N; Van Gool SW
    Int J Cancer; 2015 Mar; 136(5):E313-25. PubMed ID: 25208916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic newcastle disease virus triggers cell death of lung cancer spheroids and is enhanced by pharmacological inhibition of autophagy.
    Hu L; Sun S; Wang T; Li Y; Jiang K; Lin G; Ma Y; Barr MP; Song F; Zhang G; Meng S
    Am J Cancer Res; 2015; 5(12):3612-23. PubMed ID: 26885450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
    Fournier P; Bian H; Szeberényi J; Schirrmacher V
    Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
    Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
    Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
    Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptin enhances the oncolytic properties of Newcastle disease virus.
    Wu Y; Zhang X; Wang X; Wang L; Hu S; Liu X; Meng S
    Intervirology; 2012; 55(4):276-86. PubMed ID: 21865658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
    Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
    Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting.
    Wu Q; Jin Y; Li S; Guo X; Sun W; Liu J; Li Q; Niu D; Zou Y; Du X; Li Y; Zhao T; Li Z; Li X; Ren G
    Int Immunopharmacol; 2024 Jul; 136():112305. PubMed ID: 38823178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic targeting of androgen-sensitive prostate tumor by the respiratory syncytial virus (RSV): consequences of deficient interferon-dependent antiviral defense.
    Echchgadda I; Chang TH; Sabbah A; Bakri I; Ikeno Y; Hubbard GB; Chatterjee B; Bose S
    BMC Cancer; 2011 Jan; 11():43. PubMed ID: 21276246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy inhibition suppresses Newcastle disease virus-induced cell death by inhibiting viral replication in human breast cancer cells.
    Rozilah MI; Yusoff K; Chia SL; Ismail S
    Virology; 2024 Feb; 590():109957. PubMed ID: 38100982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma.
    Meng G; Li B; Chen A; Zheng M; Xu T; Zhang H; Dong J; Wu J; Yu D; Wei J
    Br J Cancer; 2020 Jan; 122(1):111-120. PubMed ID: 31819179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Newcastle disease virus mediated dendritic cell activation and cross-priming tumor-specific immune responses ex vivo.
    Xu Q; Rangaswamy US; Wang W; Robbins SH; Harper J; Jin H; Cheng X
    Int J Cancer; 2020 Jan; 146(2):531-541. PubMed ID: 31584185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
    Kalyanasundram J; Hamid A; Yusoff K; Chia SL
    Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model.
    He J; An Y; Qi J; Cui L; Yang K; Liu M; Qu B; Yan S; Yin J; Jing X; Dong H; Yu Q; Li D; Wu Y
    J Med Virol; 2021 Jun; 93(6):3890-3898. PubMed ID: 32779745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.
    Schirrmacher V
    Expert Opin Biol Ther; 2015; 15(12):1757-71. PubMed ID: 26436571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.